SNY vs. JNJ
Compare and contrast key facts about Sanofi (SNY) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNY or JNJ.
Correlation
The correlation between SNY and JNJ is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
SNY vs. JNJ - Performance Comparison
Loading data...
Key characteristics
SNY:
0.35
JNJ:
0.06
SNY:
0.53
JNJ:
0.28
SNY:
1.06
JNJ:
1.04
SNY:
0.27
JNJ:
0.12
SNY:
0.60
JNJ:
0.32
SNY:
9.63%
JNJ:
6.52%
SNY:
24.40%
JNJ:
19.18%
SNY:
-46.65%
JNJ:
-52.60%
SNY:
-10.61%
JNJ:
-12.12%
Fundamentals
SNY:
$121.71B
JNJ:
$357.16B
SNY:
$2.77
JNJ:
$8.87
SNY:
17.77
JNJ:
16.50
SNY:
0.82
JNJ:
1.01
SNY:
2.69
JNJ:
4.00
SNY:
1.46
JNJ:
4.57
SNY:
$43.77B
JNJ:
$89.33B
SNY:
$31.12B
JNJ:
$61.01B
SNY:
$9.61B
JNJ:
$34.70B
Returns By Period
In the year-to-date period, SNY achieves a 10.13% return, which is significantly higher than JNJ's 4.28% return. Over the past 10 years, SNY has underperformed JNJ with an annualized return of 4.18%, while JNJ has yielded a comparatively higher 6.69% annualized return.
SNY
10.13%
4.97%
11.07%
8.37%
5.62%
4.18%
JNJ
4.28%
-2.61%
0.10%
1.14%
2.74%
6.69%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNY vs. JNJ — Risk-Adjusted Performance Rank
SNY
JNJ
SNY vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
SNY vs. JNJ - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 4.35%, more than JNJ's 3.32% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNY Sanofi | 4.35% | 4.22% | 3.83% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.79% | 4.19% |
JNJ Johnson & Johnson | 3.32% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
SNY vs. JNJ - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for SNY and JNJ. For additional features, visit the drawdowns tool.
Loading data...
Volatility
SNY vs. JNJ - Volatility Comparison
Sanofi (SNY) has a higher volatility of 8.38% compared to Johnson & Johnson (JNJ) at 6.29%. This indicates that SNY's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
SNY vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SNY vs. JNJ - Profitability Comparison
SNY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Sanofi reported a gross profit of 7.72B and revenue of 10.61B. Therefore, the gross margin over that period was 72.8%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a gross profit of 14.54B and revenue of 21.89B. Therefore, the gross margin over that period was 66.4%.
SNY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Sanofi reported an operating income of 2.29B and revenue of 10.61B, resulting in an operating margin of 21.5%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported an operating income of 6.30B and revenue of 21.89B, resulting in an operating margin of 28.8%.
SNY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Sanofi reported a net income of 1.87B and revenue of 10.61B, resulting in a net margin of 17.7%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a net income of 11.00B and revenue of 21.89B, resulting in a net margin of 50.2%.